Bennett Pharmaceuticals Industry is a 100% Greek company active across the full spectrum of the pharmaceutical industry, producing high-quality generic and original formulations with investments in R&D, innovation, and new technologies. It has established itself as the fastest-growing company in the Greek pharmaceutical market.
Bennett is active in 19 countries, has a portfolio of 216 branded products, and currently has 27 new products under regulatory approval
Bennett is active in Europe (Albania, Bulgaria, Georgia, Kosovo, Cyprus, Malta, Romania, Poland, North Macedonia), Africa (Egypt, Libya, Zambia), and Asia (Azerbaijan, Vietnam, Iraq, Iran, Jordan, Kurdistan, Lebanon, Saudi Arabia, and Yemen
Bennett's manufacturing facility covers 2,500 m² & A major new investment is underway for a 17,000 m² facility at Koropi and an R&D Hub for 22,000 m² at Metamorfosi
They cover Cardiology, Psychiatry, Endocrinology, Pulmonology, and Neurology, as well as OTC products, medical devices, and nutritional supplements.
Bennett is 1st fastest growing company in Greece
2Nd largest company in the generics market in Greece
.13th overall among Greek and multinational pharmaceutical companies in Greece
external link